FirstWord Pharmaceutical News
Summary: Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional. For more information on this time-saving tool, please visit www.firstwordpharma.com.
- Visit Website
- RSS
- Artist: FirstWord
- Copyright: 2019
Podcasts:
Today in FirstWord: Avastin, AstraZeneca, antidepressants, Cymbalta, FDA
Today in FirstWord: Eli Lilly, United Therapeutics, Raptiva, Duragesic, Remodulin, telavancin
Today in FirstWord: Pfizer, Zyprexa, Lamisil, Embeda, Actavis
Today in FirstWord: Gardasil, Zevtera, Bristol-Myers Squibb, Seroquel, Avastin
Today in FirstWord: bisphosphonates, Avandia, tamoxifen, Lundbeck, Embeda
Today in FirstWord: GlaxoSmithKline, Plavix, Avapro, Multaq, OPT-80
Today in FirstWord: Crestor, Champix, Solzira, Xarelto, Remoxy
Today in FirstWord: Crestor, Amgen, Tarceva, Merck & Co., FDA
Today in FirstWord: CP-945,598, Plavix, Teva, heparin, Biovail
Today in FirstWord: GlaxoSmithKline, pharmaceutical trends, Acomplia
Today in FirstWord: Vytorin, NHS, AstraZeneca, Johnson & Johnson, Byetta LAR
Today in FirstWord: Wyeth, NHS, Avastin, NICE, paediatric drug trends
Today in FirstWord: sanofi-aventis, Toviaz, Treanda, Erbitux, GA101
Today in FirstWord: AstraZeneca, Avandia, Zoloft, GlaxoSmithKline, Genelabs, Arimidex, tamoxifen
Today in FirstWord: Pharmaceutical market growth forecasts, FDA preemption policies, Bayer, Duragesic, Tysabri